By Maarten Pieter Schinkel & Abel d’Ailly (University of Amsterdam)
Western competition authorities responded quick and united to the COVID-19 pandemic with a generous exemption from cartel law for any companies that aim to solve pressing scarcities in anticompetitive collaboration. However there is little reason to expect more supply, fair distribution, low prices or wider use of personal protective equipment from horizontal collaboration. The agencies should better have stood by competition instead. Embracing the policy might have been about public image, more than high expectations of collaboration amongst rivals contributing to solving the needs associated with COVID-19. That experimental treatment is not without side effects. By relaxing the first article of antitrust, the agencies undermined their authority, just when we need them to effectively control the many markets that are rapidly consolidating, due to the consequences of the lock-downs.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI